A Randomised Phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients.
Primary Sponsor
NCIC Clinical Trials Group (NCIC CTG)
Participating Centres
Current Accrual
Related Post
February 28, 2022
Cancer trial participant hoping to help
The RAVES trial treating prostate cancer Participating in a
June 15, 2021
Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery
Ductal carcinoma in situ (DCIS) of the breast is
